Less equivocally, Braun et al. showed that in advancing stages of ccRCC, immune dysfunction appears to be progressive, with enrichment in terminally exhausted CD8 + T cells and a shift in TAMs towards an anti-inflammatory M2-like state with a decrease in inflammatory cytokine production49. The gene discussed is CD8A; the disease is nonpapillary renal cell carcinoma.